imatinib mesylate has been researched along with Pancreatic Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Welsh, N | 1 |
1 review(s) available for imatinib mesylate and Pancreatic Diseases
| Article | Year |
|---|---|
Does the small tyrosine kinase inhibitor Imatinib mesylate counteract diabetes by affecting pancreatic islet amyloidosis and fibrosis?
Topics: Amyloidosis; Animals; Benzamides; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disease Models, Animal; Fibrosis; Humans; Imatinib Mesylate; Islets of Langerhans; Mice; Pancreatic Diseases; Piperazines; Protein Kinase Inhibitors; Pyrimidines | 2012 |